1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
investigation from the European Commission, and adverse events linked to some of its newest medicines, Zoetis has seen its share price plunge 27% this year and 40% from its all-time highs. We will get to these issues in a moment, but the silver lining to these recent developments is that Zoetis shares now trade at a once-in-a-decade valuation. So this begs the question: Is Zoetis now a fundamentally flawed business destined to continue dropping? Or is this sell-off a unique opportunity for investors willing to buy and hold for a decade and beyond? Here's why I'm leaning toward the latter. Is Zoetis stock losing its bite? Zoetis is the global leader in medicines, diagnostics, vaccines, and beyond for the companion animal (cats and dogs) and livestock (cattle, swine, horses, fish, and sheep) markets. Selling in over 100 countries, Zoetis is the global market share leader (by species) in categories that comprise over 90% of its total sales. This dominant positioning in the anim
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Global Retinoblastoma Treatment Market Size To Exceed USD 3.8 Billion By 2033 | CAGR of 4.28% [Yahoo! Finance]Yahoo! Finance
- Imre Continues its Brand AOR Evolution with Industry Veteran Christian Bauman as Chief Creative Officer [Yahoo! Finance]Yahoo! Finance
- LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead? [Yahoo! Finance]Yahoo! Finance
- Immersive Labs Unveils New ‘Dark Side of GenAI' Report about How People Trick Chatbots into Exposing Company Secrets [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/9/24 - Form S-8
- PFE's page on the SEC website